These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1799481)

  • 21. [Alpha interferon treatment in hairy cell leukemia].
    Hagberg H
    Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
    Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
    Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment.
    Troussard X; Flandrin G
    Leuk Lymphoma; 1994; 14 Suppl 1():99-105. PubMed ID: 7820062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
    Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
    Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hairy-cell leukemia: current views.
    Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
    Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic aspects of hairy cell leukemia].
    Rosa F; Casciaro S; Gatti AM; Boccaccio P; Ghio R
    Recenti Prog Med; 1989 Jan; 80(1):37-44. PubMed ID: 2469113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pentostatin and alpha interferon in splenectomized patients with active hairy cell leukemia: an intergroup study. Cancer and Leukemia Group B and South-West Oncology Group.
    Rai KR
    Leuk Lymphoma; 1994; 14 Suppl 1():107-8. PubMed ID: 7820040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in therapy for hairy cell leukemia. A review.
    Jaiyesimi IA; Kantarjian HM; Estey EH
    Cancer; 1993 Jul; 72(1):5-16. PubMed ID: 7685243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone-marrow biopsy in hairy cell leukaemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapies.
    Pileri S; Sabattini E; Poggi S; Merla E; Raspadori D; Benfenati D; Rondelli D; Benni M; Ventura MA; Falini B
    Leuk Lymphoma; 1994; 14 Suppl 1():67-71. PubMed ID: 7820056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
    Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM
    Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment.
    Fietz T; Rieger K; Schmittel A; Thiel E; Knauf W
    Hematol J; 2004; 5(5):451-2. PubMed ID: 15448675
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
    Lichtman SM; Wasil T; Ahmad M; Brody J
    Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon in the treatment of hairy-cell leukemia.
    Ahmed S; Rai KR
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):69-81. PubMed ID: 12670466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
    Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
    Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards the pharmacotherapy of hairy cell leukaemia.
    Lauria F; Forconi F
    Expert Opin Pharmacother; 2004 Jul; 5(7):1523-33. PubMed ID: 15212603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
    Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
    J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-interferon in hairy cell leukemia: an initial Indian experience.
    Malhotra H; Advani SH; Gopal R; Saikia TK; Nadkarni KS; Pai VR; Nair CN
    J Assoc Physicians India; 1992 Mar; 40(3):159-61. PubMed ID: 1634479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hairy cell leukemia. A therapeutical update.
    Damasio EE; Pagnucco G; Federico M; Annino L; Chisesi T; Lamparelli T; Lauria F; Castoldi G; Resegotti L
    Haematologica; 1989; 74(2):205-18. PubMed ID: 2473014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early response to alpha interferon in a patient affected by hairy cell leukemia.
    Di Raimondo F; Murolo D; Milone G; Cacciola E; Giustolisi R
    Haematologica; 1992; 77(4):355-6. PubMed ID: 1427445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.